Related Experiment Video
Updated: Jan 11, 2026

08:16
One-anastomosis Gastric Bypass OAGB in Rats
Published on: November 10, 2018
11.4K
Quality of Life Outcomes After Fundoplication-Augmented One-Anastomosis Gastric Bypass: A Randomized Comparative
Mostafa Mahran1, Reem Salah2, Rofida Sobh3
1Upper Gastrointestinal Surgery, Homerton University Hospital, London, GBR.
Cureus
|November 17, 2025
Summary
Adding a modified fundoplication to one-anastomosis gastric bypass (OAGB) significantly improves gastroesophageal reflux disease (GERD) symptom control and health-related quality of life (HRQoL) in obese patients. This combined approach reduces proton pump inhibitor use and enhances reflux management compared to OAGB alone.
Area of Science:
- Bariatric Surgery
- Gastroenterology
- Surgical Innovation
Background:
- Gastroesophageal reflux disease (GERD) often persists after bariatric surgery, impacting patient quality of life.
- One-anastomosis gastric bypass (OAGB) is effective for weight loss but may not fully resolve GERD symptoms.
Purpose of the Study:
- To evaluate the efficacy of incorporating a modified fundoplication with OAGB for improved GERD symptom control.
- To assess the impact on health-related quality of life (HRQoL) in patients with obesity and GERD.
Main Methods:
- A prospective randomized comparative study involving 60 patients with obesity and GERD.
- Patients were divided into two groups: OAGB alone versus OAGB with modified fundoplication.
- Outcomes assessed included upper GI findings, manometry, GERD-HRQL scores, and PPI use over two years.
Main Results:
- The OAGB with fundoplication group showed significantly better symptom control (Visick score) and reduced PPI duration compared to OAGB alone.
- Significant improvements in GERD-HRQL scores were observed in the fundoplication group at six and 24 months.
- Endoscopic and manometric evaluations at 24 months confirmed intact wraps and restored LES function without GERD evidence.
Conclusions:
- Combined OAGB and modified fundoplication significantly enhance quality of life for obese GERD patients.
- This approach offers superior symptom management, reduced PPI dependence, and improved reflux control.
- Further validation with larger studies and pH impedance monitoring is recommended.

